Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Neuropathy peripheral
ADR ID BADD_A03063
ADR Hierarchy
17      Nervous system disorders
17.09      Peripheral neuropathies
17.09.03      Peripheral neuropathies NEC
17.09.03.003      Neuropathy peripheral
Description A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA. | Inflammation of multiple nerves. [MeSH]
MedDRA Code 10029331
MeSH ID D009443; D010523
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hereditary and idiopathic peripheral neuropathy | Hereditary and idiopathic peripheral neuropathy, other | Inflammatory and toxic neuropathy | Neuritis peripheral | Neuropathy | Neuropathy - (NOS) | Neuropathy NOS | Neuropathy peripheral | Other hereditary and idiopathic peripheral neuropathy | Other inflammatory and toxic neuropathies | Other specified idiopathic peripheral neuropathy | Peripheral neuritis | Peripheral neuritis antepartum | Peripheral neuritis in pregnancy | Peripheral neuritis in pregnancy, unspecified as to episode of care | Peripheral neuritis in pregnancy, with delivery | Peripheral neuritis in pregnancy, with delivery, with mention of postpartum complication | Peripheral neuritis NOS | Peripheral neuritis postartum | Peripheral neuropathy aggravated | Peripheral neuropathy NOS | Unspecified hereditary and idiopathic peripheral neuropathy | Unspecified idiopathic peripheral neuropathy | Unspecified inflammatory and toxic neuropathies | Peripheral nerve disorder NOS | Peripheral neuritis postpartum | Cold sensitivity neuropathy | Chemotherapy induced peripheral neuropathy | Peripheral neuropathy | Neuritis | Neuritides | Neuritis, Peripheral | Neuritides, Peripheral | Peripheral Neuritides | Peripheral Neuritis | Neuritis, Sensory | Neuritides, Sensory | Sensory Neuritides | Sensory Neuritis | Polyneuritis | Polyneuritides | Neuritis, Motor | Motor Neuritides | Motor Neuritis | Neuritides, Motor
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02150Temozolomide--
BADD_D02153Teniposide--
BADD_D02154Tenofovir--
BADD_D02155Tenofovir disoproxil--
BADD_D02156Tenofovir disoproxil fumarate--
BADD_D02160Terbinafine--
BADD_D02165Teriflunomide0.022448%
BADD_D02168Tesamorelin--
BADD_D02192Thalidomide0.033394%
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02215Ticlopidine--
BADD_D02216Ticlopidine hydrochloride--
BADD_D02221Tinidazole--
BADD_D02226Tipranavir--
BADD_D02227Tipranavir disodium--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02232Tobramycin--
BADD_D02241Tolcapone--
BADD_D02247Topiramate--
BADD_D02248Topotecan0.000112%
BADD_D02249Topotecan hydrochloride--
BADD_D02250Toremifene citrate--
BADD_D02253Trabectedin--
BADD_D02264Trastuzumab--
BADD_D02270Tretinoin--
BADD_D02271Triamcinolone--
BADD_D02272Triamcinolone acetonide--
BADD_D02273Triamcinolone diacetate--
The 15th Page    First    Pre   15 16 17    Next   Last    Total 17 Pages
ADReCS-Target
ADR Term Drug Name Target